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Monday, March 7, 2011 287abinding sites retained in the differentiation process, histone modifications
H3K4m1 and H3K4me3 exhibit a dip centered at the binding sites and
sandwiched by two peaks; Whereas for MyoD binding sites that disappear
after differentiation, histone modifications H3K4m1 and H3K4me3 exhibit
a single peak centered at the binding sites. Other histone modifications
also exhibit different behaviors at the two groups of MyoD binding sites.
We will discuss the possible causes of this drastically different behavior
and their functional implications.1559-Pos Board B469
Foxo1 Nuclear-Cytoplasmic Movement in Live Skeletal Muscle Fiber
Tova Neustadt Schachter, Martin F. Schneider.
The transcription factor Foxo1 is integral to the regulation of expression of
proteins which promote muscle atrophy. Phosphorylation of Foxo1 causes its
translocation to the cytoplasm and thus prevents Foxo1-DNA binding and
consequent transcription of genes that cause muscle atrophy and cell death.
Thus, phosphorylation of Foxo1 leads to cell survival and muscle hypertro-
phy. Maintenance of Foxo1 phosphorylation and its resulting cytoplasmic re-
tention could be used to suppress muscle atrophy and thereby shift the
atrophy/hypertrophy balance in favor of hypertrophy. This in turn may be
utilized to develop therapeutic avenues in treatment of muscle wasting as
seen in patients with denervation, age-related muscle wasting, and AIDS.
Akt and serum- and glucocorticoid-inducible kinase (SGK) are important
regulators of the phosphorylation status of Foxo1. These pathways have
been well characterized and the effects on Foxo1 localization have been re-
ported. However, the mechanisms which regulate nuclear influx and nuclear
efflux have not been separately evaluated. Here, we determine the effects of
Akt kinase activity specifically on nuclear influx of Foxo1. To accomplish
this goal, we quantified nuclear and cytoplasmic levels of adenovirally ex-
pressed Foxo1-GFP in cultured flexor digitorum brevis. The nuclear influx
during treatment with kinase inhibitor Akt IV alone and in combination
with the nuclear efflux inhibitor lemptomycin B provides insight into the ac-
tivity of Akt as a Foxo1 kinase. Surprisingly, Akt inhibition reveals Akt to
have little effect on the rate of nuclear influx of Foxo1. To evaluate translo-
cation of endogenous Foxo1 in a similar manner immunocytochemistry and
western blotting techniques were used. These results indicate that Akt either
phosphorylates Foxo1 primarily in the nucleus and not in the cytoplasm, or
that there is a mechanism for cytoplasmic phosphorylation of Foxo1 other
than via Akt. Supported by NIH-NIAMS Grants R01-AR056477 and T32-
AR007592.1560-Pos Board B470
Dynamic Skeletal Muscle Exercise and Fatigue Development in Post In-
farction Heart Failure Rats and Effect of Warm-Up
Kristin H. Hortemo, Ole M. Sejersted, Per K. Lunde.
Skeletal muscle fatigue develops during physical exercise. Most reports on
skeletal muscle fatigue use isometricfatigue protocols with a fall in force pro-
duction as a measure of fatigue. However, most muscles shorten during normal
use and we propose that the fatigue mechanism will be different during dy-
namic contractions as compared with isometric contractions.
Methods: Fatigue was induced in rat soleus muscles from post infarction heart
failure (HF) rats and controls (SHAM) by in situ isotonic shortening contrac-
tions (1s at 30Hz every 2s for 15min). The muscles were allowed to shorten iso-
tonically against a load (AL) corresponding to 1/3 of maximal isometric force.
After 15min recovery period the muscles were stimulated with a similar proto-
col. MLC2s phosphorylation and metabolites were measured at different points
of time.
Results: During 1st protocol, fatigue development was confirmed by a signifi-
cant fall in shortening in both SHAM and HF. After 100s of stimulation soleus
from SHAM showed an increase in baseline tension (Tbl) between stimulation
trains, which was much less pronounced in HF (p<0.01). At this time there was
a significant higher lactate concentration in SHAM muscle compared with HF.
The increase in Tbl at 100s was correlated to both isotonic and isometric relax-
ation rate. At 100s in 2nd protocol, the isotonic and isometric relaxation rates
were nearly recovered leading to almost no rise in Tbl in both SHAM and
HF. There was a linear correlation (p=0.99) between maximal shortening and
MLC2s phosphorylation in protocols with variable AL. We propose that
MLC2s phosphorylation participates in the regulation of shortening, while me-
tabolites (especially lactate) may contribute to the reduced relaxation rates
leading to increased Tbl.1561-Pos Board B471
Time Resolved Analyses of Gene Expression in a Rodent Icu Model
Monica Llano-Diez, Ann-Marie Gustafson, Hanna Goransson, Carl Olsson,
Lars Larsson.
Intensive care unit (ICU) patients commonly develop severe skeletal muscle
wasting that aggravate the recovery from the primary disease and weaning
from respirator. The modern treatment in anesthesiology and intensive
care can progress in Acute Quadriplegic Myopathy (AQM). This study
aims at improving our understanding of the mechanisms underlying the
muscle wasting and weakness in ICU patients with AQM. Specific interest
is focused on duration-dependent effects on intracellular signaling and myo-
fibrillar gene and protein expression. For that reason, a unique experimental
rat model mimicking ICU such as mechanical ventilation, muscle unloading,
neuromuscular blocking agents (NMBA) administration and monitoring at
different time points from 6h to 14 days, was used. Gene expression profile
was analyzed in gastrocnemius muscle, showing an increased expression in
the muscle-specific ubiquitin ligases, atrogin-1 and MuRF-1 after 6 h, as
well as other genes involved in translational repression, authophagic/lyso-
somal genes (LC3b, cathepsins), oxidative stress response and up-regulation
of pro-apoptosis signaling, except caspase-3 that increased after 9 days of
intervention. Metalloproteins, GST, cystatins and cell cycle repressors
were up-regulated in the early stages in response to oxidative stress and cel-
lular damage among other genes, while LIM and sarcomeric proteins, colla-
gen, extracellular matrix transcripts, carbohydrate metabolism, mitochondrial
genes and the muscle-specific calpain-3 were down-regulated mainly after 5
days.
These results suggest a very complex, unique and highly temporally coordi-
nated activation of protein synthesis, degradation, protective mechanisms
and intracellular signaling activation at different time points during ICU con-
ditions.1562-Pos Board B472
A novel Splicing Factor that Affects Titin Alternative Splicing
Wei Guo, Marion Greaser, Shijun Li, Herbert Schulz, Kathrin Saar,
Michael Radke, Timothy A. Hacker, Kurt W. Saupe, Padmanabhan Vakeel,
Thirupugal Govindarajan, Norbert Hubner, Michael Gotthardt.
Cardiac muscle expresses predominantly larger N2BA titin isoforms at em-
bryonic and prenatal stages of development, and these are mostly replaced
with a smaller N2B isoform in adults. We have previously discovered a mu-
tation in rats that dramatically alters titin splicing (Greaser et al J Mol Cell
Cardiol 44:982, 2008). To determine the mechanism responsible for this
change in titin splicing, we performed genetic linkage analysis with 191 an-
imals from two different backcrosses. The titin splicing factor mutation was
mapped to the long arm of chromosome 1 using a 10K SNP chip. PCR ver-
ified that the mutation occurs as a large deletion of an RS type splicing fac-
tor. The deletion was further verified by Southern blot, qPCR, and western
blot analysis. Immunofluorescence staining of cardiomyocytes and HL1 cells
indicated that the splicing factor was localized in the nucleus. Insertion of
adenovirus constructs of the factor into homozygous mutant cardiomyocytes
restored wild type titin splicing. The mutant rats show significantly larger left
ventricle (LV) diameter in diastole and lower ejection fractions. Heart rate
response to dobutamine was blunted in both heterozygote and homozygote
mutants compared to wild type. Histological observations after Masson tri-
chrome staining showed that fibrosis was significantly increased in LV
from the same groups as compared to wild type hearts. An increased percent-
age in sudden death occurred in heterozygotes and homozygous mutants after
10 months of age. The splicing factor is mainly expressed in cardiac muscle
and skeletal muscle as determined by Western blotting. Although heterozy-
gote and homozygote mutants survive and reproduce, the titin splicing factor
is required for normal cardiac structure and function. Supported by NIH
HL77196.1563-Pos Board B473
Preventing Ryanodine Receptor 1 calcium Leak Improves Age-Dependent
Muscle Dysfunction
Daniel C. Andersson, Mathew J. Betzenhauser, Steven Reiken, Albano
C. Meli, Wenjun Xie, Alain Lacampagne, Andrew R. Marks.
A hallmark of mammalian aging is the progressive decline in muscle func-
tion, referred to as sarcopenia. It is commonly found that the force-generat-
ing capacity of aged muscle is reduced when normalized to the muscle cross-
288a Monday, March 7, 2011sectional area (specific force). This indicates defective excitation-contraction
coupling. In this process, sarcoplasmic reticulum (SR) Ca2þ release via the
ryanodine receptor 1 (RyR1) is a pivotal step that grades muscle contractile
force. It has previously been shown that impaired contractility and SR Ca2þ
release in muscular dystrophy can be caused by excessive RyR1-cysteine ni-
trosylation and reduced binding of the stabilizing protein FK506 binding pro-
tein 12 (FKBP12 or calstabin1) to RyR1. We hypothesized that
maladaptations in the RyR1-SR Ca2þ release system could underlie impaired
muscle function also in aging. Using immunoprecipitation and immuonblot-
ting, we found that RyR1 from aged (24-26 month) mouse muscle were ox-
idized, cysteine-nitrosylated, and depleted of FKBP12, compared to RyR1
from younger (3-6 months) adult mice. This remodeling of the RyR1 re-
sulted in ‘‘leaky’’ channels, which displayed an increased open probability
and Ca2þ spark frequency.Moreover, tetanic Ca2þ transients and muscle spe-
cific forcewere reduced in 24-month-old mice. Treating aged mice with the
RyR-stabilizing compound, S107, restored RyR1-FKBP12 interaction, and
improved tetanic Ca2þ release, muscle specific force and exercise capacity.-
Together, these findings highlight the role of impaired SR Ca2þ release in
age-dependent muscle weakness and introduce a novel therapeutic target
for sarcopenia.1564-Pos Board B474
Pge2 Accelerates Myogenesis of C2c12 Myoblasts
ChengLin Mo, Sandra Romero-Suarez, Marco A. Brotto.
Prostaglandin E2 (PGE2), a modulator of physiological responses including in-
flammation, fever, and smooth muscle tone, is a prostanoid synthesized from
arachidonic acid via the cyclooxygenase pathway.PGE2 is released in large
amounts by injured muscle fibers, and is linked to muscle regeneration by reg-
ulating myoblast fusion. However, the physiological roles and related molecu-
lar mechanisms of PGE2 on skeletal muscle function remain elusive. We used
C2C12 cells, to investigate the functional, cellular, and molecular effects of
PGE2. Treatment of C2C12 myoblasts to 50nM PGE2 resulted in accelerated
myogenesis when compared to the naturally potent effects of differentiating
media containing 2.5% horse serum. To investigate the genetic mechanisms un-
derlying these effects, we used a custom-built 96 real-time gene PCR array to
search for genes and pathways that might help explain the myogenic effects of
PGE2. We discovered that PGE2 robustly upregulates the MURF-NFKB cal-
cium-dependent myogenic pathway in C2C12 myoblasts. We are now studying
the functional and cell biological consequences of PGE2 effects and its roles in
muscle myogenesis and differentiation.
(Support: NIH-NIAMS Recovery Act GO Grant 1RC2AR058962-01, Miossuri
Life Sciences Research Board, UMKC Center of Excellence in Mineralized
Tissue Research)1565-Pos Board B475
Pinha˜O-Manso: A Native Jatropha Curcas from Brazil Protects Muscle
Cells from Ethanol Toxicity and Improves Muscle Function
Leticia Brotto, Luis Paulillo, Edjacy Lopes, ChengLin Mo, Janalee Isaacson,
Pedro Carneiro, Luciene Lessa, Sandra Romero-Suarez, Eduardo Abreu,
Marco A. Brotto.
Jatropha curcas is a perennial plant of the spurge family (Euphorbiaceae) typ-
ical of semi-arid regions in the world spanning from Brazil to China. Recently,
it has received much attention as a potential source of vegetable oil as a replace-
ment for petroleum, and, in particular, the production of biodiesel. An under-
study aspect of this plant relates to its potential utilization as
a pharmacological agent. Interestingly, the native plant (Pinha˜o-Manso, PM)
of the semi-arid region of Brazil has been used as an ant-fatigue agent and
also for healing of abrasions, cuts, and wounds.We used C2C12 muscle cells
in the myoblast stage to begin our investigation of the functional, cellular,
and molecular effects of PM. Overnight exposure of C2C12 myoblasts to 3%
ethanol (vehicle) induced 100% cell death. We document here a fascinating re-
sult: when C2C12 were exposed to the same concentration of ethanol but in the
presence of PM, cell death was prevented. Furthermore, in ex-vivo, intact iso-
lated muscles from mice (extensor digitorum longus and soleus muscles); PM
increased contractile force production and also prevented the toxic effects of
alcohol on muscle function. We are now focusing on purification of active prin-
ciple(s) of PM that might underlie its potent and beneficial effects on muscle
function. We are also studying the molecular machinery that is modulated by
PM. Our studies indicate that native Jatropha curcas from Salvador, Brazilcould have potential applications for improvement of skeletal muscle function.
(Support: Conselho Nacional de Pesquisa-CNPq, Brazil and National Institutes
of Health, USA).1566-Pos Board B476
Transcriptional Repression of Caveolin-1 gene Expression by Gata-6 in
Bladder Smooth Muscle Hypertrophy in Mice and Humans
Ettickan Boopathi, Cristiano Mendes Gomes, Robert Goldfarb, Mary
John John, Vittala Gopal Srinivasan, Jaber Alanzi, S Bruce Malkowicz,
Hasmeena Kathuria, Stephen A. Zderic, Alan J. Wein, Samuel K. Chacko.
Caveolin-1 is a structural and functional protein of caveolae that function as
signaling platforms to mediate interaction between receptor proteins and
adaptor and effector molecules to regulate signal generation, amplification,
and diversification. Hypertrophied bladder smooth muscle (BSM) from the
rabbit model of partial bladder outlet obstruction (PBOO) and men with be-
nign prostatic hyperplasia (BPH)-induced PBOO shows a downregulation of
Caveolin-1 and caveolar structural alteration. Here we report that caveolin-1
expression is diminished in PBOO-induced BSM hypertrophy in mice and in
men with BPH. We characterized the proximal promoterof the human and
mouse caveolin-1 gene and found that the transcriptionfactor GATA-6 binds
this promoter, causing reduced expression of caveolin-1. Furthermore, we
demonstrate that caveolin-1 expression levels inversely correlate with the
abundance of GATA-6 in BSM hypertrophy in mice and humans. Impor-
tantly, silencing of GATA-6 gene expression up-regulates caveolin-1 expres-
sion, whereas overexpression of GATA-6 protein sustains the transcriptional
repression of caveolin-1 in BSM cells. Together, our data suggest that
GATA-6 acts as a transcriptional repressor of caveolin-1 gene expression
in PBOO-induced BSM hypertrophy in men and mice. The GATA-6-induced
transcriptional repression represents a new regulatory mechanism for caveo-
lin-1 gene expression in pathologic BSM. Regulating the GATA-6 transcrip-
tional regulation may serve as a target for new therapy for BPH-induced
bladder dysfunction in aging men. Supported by O’Brien Urology Center
Grant P50 DK0526201567-Pos Board B477
Between a Rock and a Hard Place: Mitochondria Deform Anisotropically
in Intact Cardiomyocytes During Active Contraction
Yael Yaniv, Magdalena Juhaszova, Su Wang, Kenneth W. Fishbein, H
Bradley Nuss, Steven J. Sollott.
The cardiomyocyte cytoskeleton, composed of rigid and elastic elements,
maintains the shape of an elongated cylinder with an eccentrically-ellipsoidal
cross-section, even during contraction-relaxation cycles. Mitochondria are mi-
cron-sized fluid-filled passive spheres distributed throughout the cardiomyo-
cyte in a crystal-like lattice in pairs sandwiched between the sarcomere
contractile machinery, longitudinally and radially; thus, their shape represents
the balance of forces in 3D extant at any given moment. We developed a novel
method to examine the average deformation of mitochondrial dimensions in
3D, in response to cardiomyocyte contraction and relaxation, to understand
how dynamic forces are balanced inside the cardiomyocytes. The optical con-
trast provided by the periodic lattice of myofilaments alternating with rows of
mitochondria was analyzed by examining the appropriate peaks in the fre-
quency spectrum image along the respective cardiomyocyte axes. This tech-
nique enables precise resolution of changes in dimension of ~1% in ~1 mm
(long axis) structures with a time resolution of 8 msec.
During active contraction (1 Hz stimulation) the mitochondria deform along
the length-and width-axes with similar time-to-peak deformation and 50%
and 90% deformation duration characteristics in both sarcomere and mito-
chondrial structures. However, significant deformation anisotropy was ob-
served between the orthogonal short (i.e., width & depth) axes of
mitochondria during electrical stimulation. Interestingly, the same degree of
deformation anisotropy was found between the myocyte orthogonal short
axes during the same electrical stimulation; therefore, the mitochondria reflect
the overall cell behavior, and the apparent stiffness and stress/strain character-
istics of the cytoskeleton differ appreciably between the cardiomyocyte or-
thogonal short axes. This method may be applied to obtaining a better
understanding of the dynamic force-balance inside cardiomyocytes and of
changes in the cytoskeleton spatial stiffness characteristics that may accom-
pany aging or pathological conditions.
